NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

SciClone Pharmaceuticals, Inc. 

901 Mariner's Island Boulevard
Suite 205
San Mateo  California  94404  U.S.A.
Phone: 650-358-3456 Fax: 650-358-3469


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Sigma-Tau Pharmaceuticals  European Union partner for the development and commercialization of ZADAXIN in Europe.





 Company News
SciClone Pharmaceuticals, Inc. (SCLN) Announces Presentations of SCV-07 Data at Upcoming Medical Meetings 11/13/2009 9:56:17 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) Q3 Tops Estimates, Raises '09 View 11/9/2009 6:37:38 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) to Cut 17% US Jobs, Take Related Charge 10/28/2009 7:15:43 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) Announces Enrollment of First Patient in Its Phase 2 Trial of SCV-07 in Hepatitis C 10/21/2009 11:26:27 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development 10/5/2009 6:50:13 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) to Present at Two September Investor Conferences 9/9/2009 1:26:31 PM    More...
SciClone Pharmaceuticals, Inc. (SCLN) to Present at the Rodman & Renshaw Annual Global Investment Conference 9/8/2009 11:04:43 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) Reports Financial Results and Provides Pipeline Update for the Second Quarter of 2009 8/5/2009 11:09:57 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 8/3/2009 10:21:33 AM    More...
SciClone Pharmaceuticals, Inc. (SCLN) Announces Appointment of Jon S. Saxe as Chairman of Board of Directors 7/31/2009 11:02:58 AM    More...
12345678910...